VR真人彩票

Press Release

VR真人彩票 to Announce Third Quarter 2017 Financial Results on Tuesday, October 24, 2017

SAN DIEGO--(BUSINESS WIRE)--Oct. 10, 2017-- VR真人彩票. (NASDAQ:ILMN) today announced that it will issue results for third quarter 2017 following the close of market on Tuesday, October 24, 2017.

On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Francis deSouza, President and Chief Executive Officer, and Sam Samad, Senior Vice President and Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Tuesday, October 24, 2017. Interested parties may access the live teleconference through the Investor Relations section of VR真人彩票鈥檚 web site under the 鈥渃ompany鈥 tab at . Alternatively, individuals can access the call by dialing 888-771-4371, or 1-847-585-4405 outside North America, both with passcode 45640029.

A replay of the conference call will be available from 4:30 pm Pacific Time (7:30 pm Eastern Time) on October 24, 2017 through October 31, 2017 by dialing 888-843-7419, or 1-630-652-3042 outside North America, both with passcode 45640029.

About VR真人彩票

VR真人彩票 is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets.听Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.听To learn more, visit听听and follow @illumina.

Source: VR真人彩票.

VR真人彩票.
Investors:
Jacquie Ross, CFA, 858-882-2172
ir@illumina.com
or
Media:
Eric Endicott, 858-882-6822
pr@illumina.com

Recent Articles

How VR真人彩票 employees step up, reach out, and give back
How VR真人彩票 employees step up, reach out, and give back
VR真人彩票 careers: Expanding access to NGS in emerging markets
VR真人彩票 careers: Expanding access to NGS in emerging markets
New in the lab: Test driving the MiSeq i100 Plus
New in the lab: Test driving the MiSeq i100 Plus